Potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases may already be out there in ...

Vanderbilt ALS Research Center (VARC) is using open science--pooling and sharing global research to help find a cure for ALS, ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) said on Thursday that it presented results from its Phase 2 DAZALS study of ...

Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

A country music singer was involved in a deadly crash Sunday night in Nashville, his attorney confirmed to WSMV. (Source: WSMV) ...

Usnoflast is an orally available small molecule that's designed to reduce inflammation, a key contributor to nerve cell ...

UC Irvine researchers conducted a study to better understand the molecular basis of amyotrophic lateral sclerosis (ALS), a ...

Corcept Therapeutics has tried to cast its recent phase 2 amyotrophic lateral sclerosis (ALS) failure in a more flattering ...

Prescribed use of anti-anxiety drugs, hypnotics and sedatives, or antidepressants was tied to a higher future risk of ...

Corcept Therapeutics' dazucorilant failed the primary ALS trial goal but showed improved survival outcomes and a safe profile ...

Microglia — immune cells in the brain and spinal cord — play crucial roles in keeping the brain healthy, including helping ...